Decreased brain protein levels of cytochrome oxidase subunits in Alzheimer's disease and in hereditary spinocerebellar ataxia disorders: A nonspecific change?

Journal of Neurochemistry

Volumn 72, Issue 2, 1999, Pages 700-707

  Kish, Stephen J ^d   Mastrogiacomo, Frank ^d   Guttman, Mark ^d   Furukawa, Yoshiaki ^d   Taanman, Jan Willem ^a   Dožić, Slobodan ^b   Pandolfo, Massimo ^e   Lamarche, Jacques ^c   DiStefano, Linda ^d   Chang, Li Jan ^d  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

^d CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^e Hum Neurochemical Pathol Lab Ctr for Addiction and Mental Health Clarke Division ^*

Author keywords

Alzheimer's disease; Complex IV; Cytochrome oxidase; Friedreich's ataxia; Mitochondria; Oxidative phosphorylation; Spinocerebellar ataxia type I

Indexed keywords

BRAIN PROTEIN; CELL NUCLEUS DNA; CITRATE SYNTHASE; CYTOCHROME C OXIDASE; MITOCHONDRIAL DNA;

ALZHEIMER DISEASE; ARTICLE; ATAXIA; BRAIN DEGENERATION; CEREBELLUM CORTEX; CONTROLLED STUDY; ENZYME SUBUNIT; FRIEDREICH ATAXIA; FRONTAL CORTEX; GENETIC DISORDER; HUMAN; HUMAN TISSUE; OCCIPITAL CORTEX; PARIETAL LOBE; PRIORITY JOURNAL; SPINOCEREBELLAR ATAXIA; TEMPORAL CORTEX;

EID: 0032944035     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.0720700.x     Document Type: Article

References (54)

1. Beal M. F. (1997) New techniques for investigating mitochondrial DNA in neurodegenerative diseases. Neurology 49, 907-908.
2. Butterworth J. and Tennant M. C. (1989) Postmortem human brain pH and lactate in sudden infant death syndrome. J. Neurochem. 53, 1494-1499.
3. Campuzano V., Montermini L., Moltò M. D., Pianese L., Cossee M., Cavalcanti F., Monrog E., Rodius F., Duclos F., Monticelli A., Zara F., Canizawa J., Koutnikova H., Bidichandani S. I., Gellera C., Brice A., Trouillas S. P., DiMichele G., Filla H., DeFrutos R., Palau F., Patel P. I., DiDorato S., Mandel J.-L., Cocozza S., Koenig M., and Pandolfo M. (1996) Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 271, 1423-1427.
4. Capaldi R. A., Marusich M. F., and Taanman J.-W. (1995) Mammalian cytochrome-c oxidase: characterization of enzyme and immunological detection of subunits in tissue extracts and whole cells. Methods Enzymol. 260, 117-132.
5. Cavelier L., Jazin E. E., Eriksson I., Prince J., Bave U., Oreland L., and Gyllensten U. (1995) Decreased cytochrome-c oxidase activity and lack of age-related accumulation of mitochondrial DNA deletions in the brains of schizophrenics. Genomics 29, 217-224.
6. Chagnon P., Bétard C., Robitaille Y., Cholette A., and Gauvreau D. (1995) Distribution of brain cytochrome oxidase activity in vari-ous neurodegenerative diseases. Neuroreport 6, 711-715.
7. - sion in Alzheimer's disease. Mol. Brain Res. 24, 336-340.
8. Chandrasekaran K., Hatanpää K., Rapoport S. I., and Brady D. R. (1997) Decreased expression of nuclear and mitochondrial DNA-encoded genes of oxidative phosphorylation in association neocortex in Alzheimer disease. Mol. Brain Res. 44, 99-104.
9. 2+ exchange activity is increased in Alzheimer's disease brain tissues. Brain Res. 543, 139-147.
10. Cooper J. M., Wischik C., and Schapira A. H. V. (1993) Mitochondrial function in Alzheimer's disease. Lancet 341, 969-970.
11. Davis J. N. II and Parker W. D. Jr. (1998) Evidence that two reports of mtDNA cytochrome c oxidase "mutations" in Alzheimer's disease are based on nDNA pseudogenes of recent evolutionary origin. Biochem. Biophys. Res. Commun. 244, 877-883.
12. Davis R. E., Miller S., Herrnstadt C. Ghosh S. S., Fahy E., Shinobu L. A., Galsko D., Thal L. J., Beal M. F., Howell N., and Parker W. D. Jr. (1997) Mutations of mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer's disease. Proc. Natl. Acad. Sci. USA 94, 4526-4531.
13. Fujita K., Yamauchi M., Shibayama K., Ando M., Honda M., and Nagata Y. (1996) Decreased cytochrome c oxidase activity but unchanged superoxide dismutase and glutathione peroxidase activities in the spinal cord of patients with amyotrophic lateral sclerosis. J. Neurosci. Res. 45, 276-281.
14. Fukuyama H., Ogawa M., Yamauchi H., Yamaguchi S., Kimura J., Yonekura Y., and Konishi J. (1994) Altered cerebral energy metabolism in Alzheimer's disease: a PET study. J. Nucl. Med. 35, 1-6.
15. Gabuzda D. H., Busciglio J., Chen L. B., Matsudaira P., and Yankner B. A. (1994) Inhibition of energy metabolism alters the processing of amyloid precursor protein and induces a potentially amyloidogenic derivative. J. Biol. Chem. 269, 13623-13628.
16. Geoffroy G., Barbeau A., Breton G., Lemieux B., Aube M., Leger C., and Bouchard J. P. (1976) Clinical description and roentgenologic evaluation of patients with Friedreich's ataxia. Can. J. Neurol. Sci. 3, 279-286.
17. Gu M., Gash M. T., Mann V. M., Javoy-Agid F., Cooper J. M., and Schapira A. H. V. (1996) Mitochondrial defect in Huntington's disease caudate nucleus. Ann. Neurol. 39, 385-389.
18. Hardy J. A., Wester P., Winblad B., Gezelius C., Bring G., and Eriksson A. (1985) The patients dying after long terminal phase have acidotic brains: implications for biochemical measurements on autopsy tissue. J. Neural Transm. 61, 253-264.
19. Hevner R. and Wong-Riley M. T. T. (1989) Brain cytochrome oxidase: purification, antibody production, and immunohistochemical, histochemical correlations in the CNS. J. Neurosci. 9, 3884-3898.
20. Hirano M., Shtilbans A., Mayeux R., Davidson M. M., DiMauro S., Knowles J. A., and Schon E. A. (1997) Apparent mtDNA heteroplasmy in Alzheimer's disease patients and in normals due to PCR amplification of nucleus-embedded mtDNA pseudogenes. Proc. Natl. Acad. Sci. USA 94, 14894-14899.
21. Honer W. G., Dickson D. W., Gleeson J., and Davies P. (1992) Regional synaptic pathology in Alzheimer's disease. Neurobiol. Aging 13, 375-382.
22. Junck L., Gilman S., Gebarski S. S., Koeppe R. A., Kluin K. J., and Markel D. S. (1994) Structural and functional brain imaging in Friedreich's ataxia. Arch. Neurol. 51, 349-355.
23. Kish S. J. (1997) Brain energy metabolizing enzymes in Alzheimer's disease: α-ketoglutarate dehydrogenase complex and cytochrome oxidase. Ann. NY Acad. Sci. 826, 218-228.
24. Kish S. J., Bergeron C., Rajput A., Dozic S., Mastrogiacomo F., Chang L.-J., Wilson J. M., DiStefano L. M., and Nobrega J. N. (1992) Brain cytochrome oxidase in Alzheimer's disease. J. Neurochem. 59, 776-779.
25. Lamarche J. B., Lemieux B., and Lieu H. B. (1984) The neuropathology of "typical" Friedreich's ataxia in Quebec. Can. J. Neurol. Sci. 11, 592-600.
26. Leuba G. and Kraftsik R. (1994) Visual cortex in Alzheimer's disease: occurrence of neuronal death and glial proliferation, and correlation with pathological hallmarks. Neurobiol. Aging 15, 29-43.
27. Masliah E., Terry R. D., Alford M., DeTeresa R., and Hansen L. A. (1991) Cortical and subcortical patterns of synaptophysin-like immunoreactivity in Alzheimer's disease. Am. J. Pathol. 138, 235-246.
28. Matthew E., Nordahl T., Schut L., King A. C., and Cohen R. (1993) Metabolic and cognitive changes in hereditary ataxia. J. Neurol. Sci. 119, 134-140.
29. Maurer I., Zierz S., Möller H.-J., and Jerusalem F. (1995) Cytochrome c oxidase in Alzheimer's disease [Letter]. Neurology 45, 1423.
30. Mirra S. S., Heyman A., McKeel D., Sumi S. M., Crain B. J., Brownlee L. M., Vogel F. S., Hughes J. P., Van Belle G., and Berg L. (1991) The Consortium to Establish Assessment of Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41, 479-486.
31. Mountjoy C. Q., Roth M., Evans N. J. R., and Evans H. M. (1983) Cortical neuronal counts in normal elderly controls and demented patients. Neurobiol. Aging 4, 1-11.
32. Mutisya E. M., Bowling A. C., and Beal M. F. (1994) Cortical cytochrome oxidase activity is reduced in Alzheimer's disease. J. Neurochem. 63, 2179-2184.
33. Nie F. and Wong-Riley M. T. T. (1996) Mitochondrial- and nuclear-encoded subunits of cytochrome oxidase in neurons: differences in compartmental distribution, correlation with enzyme activity, and regulation by neuronal activity. J. Comp. Neurol. 373, 139-155.
34. Orr H. T., Chung M.-Y., Banfi S., Kwiatkowski T. J. Jr., Servadio A., Beaudet A. L., McCall A. E., Duvick L. A., Ranum L. P. W., and Zoghbi H. Y. (1993) Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nat. Genet. 4, 221-226.
35. Parker W. D. Jr. and Parks J. K. (1995) Cytochrome c oxidase in Alzheimer's disease brain: purification and characterization. Neurology 45, 482-486.
36. Parker W. D. Jr. and Davis R. E. (1997) Primary mitochondrial DNA defects as a causative event in Alzheimer's disease, in Mitochondria and Free Radicals in Neurodegenerative Diseases (Beal M. F., Howell N., and Bodis-Wollner I., eds), pp. 319-333. Wiley-Liss, New York.
37. Parker W. D., Filley C. M., and Parks J. D. (1990) Cytochrome oxidase deficiency in Alzheimer's disease. Neurology 40, 1302-1303.
38. Parker W. D. Jr., Parks J., Filley C. M., and Kleinschmidt-DeMasters B. K. (1994) Electron transport chain defects in Alzheimer's disease brain. Neurology 44, 1090-1096.
39. Perry E. K., Perry R. H., and Tomlinson B. E. (1982) The influence of agonal status on some neurochemical activities of postmortem human brain tissue. Neurosci. Lett. 29, 303-307.
40. Pietrini P., Furey M. L., Graff-Radford N., Freo U., Alexander G. E., Grady C. L., Dani A., Mentis M. J., and Schapiro M. B. (1996) Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease: clinical implications. Am. J. Psychiatry 153, 1261-1268.
41. Prince J. A., Yassin M. S., and Oreland L. (1997) Neuroleptic-induced mitochondrial enzyme alterations in the rat brain. J. Pharmacol. Exp. Ther. 280, 261-267.
42. Reichmann H., Flörke S., Hebenstreit G., Schrubar H., and Riederer P. (1993) Analyses of energy metabolism and mitochondrial genome in post-mortem brain from patients with Alzheimer's disease. J. Neurol. 240, 377-380.
43. Robitaille Y., Schut L., and Kish S. J. (1995) Structural and immunocytochemical features of SCA-1-linked olivopontocerebellar atrophy define a unique phenotype. Acta Neuropathol. 90, 572-581.
44. 1 reductase (complex I) deficiency in Parkinson's disease. J. Neurochem. 55, 2142-2145.
45. Simonian N. A. and Hyman B. T. (1993) Functional alterations in Alzheimer's disease: diminution of cytochrome oxidase in the hippocampal formation. J. Neuropathol. Exp. Neurol. 52, 580-585.
46. Simonian N. A. and Hyman B. T. (1994) Functional alterations in Alzheimer's disease: selective loss of mitochondrial-encoded cytochrome oxidase mRNA in the hippocampal formation. J. Neuropathol. Exp. Neurol. 53, 508-512.
47. Swerdlow R. H., Parks J. K., Cassarino D. S., Maguire D. J., Maguire R. S., Bennett J. P., Davis R. E., and Parker W. D. Jr. (1997) Cybrids in Alzheimer's disease: a cellular model of the disease? Neurology 49, 918-925.
48. Taanman J. W. (1997) Human cytochrome c oxidase: structure, function, and deficiency. J. Bioenerg. Biomembr. 29, 151-163.
49. Taanman J.-W., Burton M. D., Marusich M. F., Kennaway N. G., and Capaldi R. A. (1996) Subunit specific monoclonal antibodies show different steady-state levels of various cytochrome-c oxidase subunits in chronic progressive external ophthalmoplegia. Biochim. Biophys. Acta 1315, 199-207.
50. Van Kuilenburg A. B., Gorren A. C., Dekker H. L., Nieber P., Van Gelder B. F., and Muijgers A. O. (1992) Presteady-state and steady-state kinetic properties of human cytochrome c oxidase. Identification of rate-limiting steps in mammalian cytochrome c oxidase. Eur. J. Biochem. 205, 1145-1154.
51. Wallace D. C., Stugard C., Murdock D., Schurr T., and Brown M. D. (1997) Ancient mtDNA sequences in the human nuclear genome: a potential source of errors in identifying pathogenic mutations. Proc. Natl. Acad. Sci. USA 94, 14900-14905.
52. Wong-Riley M. T. T. (1989) Cytochrome oxidase: an endogenous metabolic marker for neuronal activity. Trends Neurosci. 12, 94-101.
53. Wong-Riley M., Antuono P., Ho K.-C., Egan R., Hevner R., Liebl W., Huang Z., Rachel R., and Jones J. (1997) Cytochrome oxidase in Alzheimer's disease: biochemical, histochemical, and immunohistochemical analyses of the visual and other systems. Vision Res. 24, 3593-3608.
54. Yates C. M., Butterworth J., Tennant M. C., and Gordon A. (1990) Enzyme activities in relation to pH and lactate in Alzheimer-type and other dementias. J. Neurochem. 55, 1624-1630.